SUBSCRIBE
Drivetime Radio

Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.

Current disciplines include:

  • Dentist, hosted by Dr Patrick Meaney
  • Epilepsy, hosted by Prof Mark Cook, Neurologist, Melbourne
  • Endocrinology, hosted by Prof Rod Baber, Obstetrician & Gynaecologist, Sydney
  • Neurology, hosted by Prof Mark Cook, Neurologist, Melbourne
  • Ophthalmology, hosted by Prof Paul Mitchell, Ophthalmologist, Sydney
  • Psychiatry, hosted by Prof Malcolm Hopwood, Psychiatrist, Melbourne
  • Respiratory, hosted by Prof John Upham, Respiratory Physician, Brisbane
  • Haematology, hosted by Prof Christ Ward, Haematologist, Royal North Shore Hospital, Sydney
  • More disciplines coming soon…

A podcast of the specialty series is available to download, providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions You can also listen online – search by your area of interest to filter interviews relevant to you.

Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.

Search Interviews

By area of interest:

Specialty Interviews

Res.5.2COPD treatment and the findings from the IMPACT study (13 mins)
00:00
Preview
10 seconds
Show more information

Respiratory. In this interview we discuss a recent study, the IMPACT study, which has looked at exacerbations and all-cause mortality differences in a head to head study comparing a number of inhaler strategies. This is an important study which answers some really important clinical questions.

Hosted by

Professor John Upham

Interviewees

  • Professor Greg King, Respiratory Physician, Royal North Shore Hospital, SydneyProfessor Greg King, Respiratory Physician, Royal North Shore Hospital, Sydney
Psy.4.1Key findings from the Metabolic Management during Antipsychotic Prescribing (MMAP) program (23 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry. People with schizophrenia are well known to be at risk of metabolic syndrome, and some of the medications we use increase that risk quite markedly. Recently an audit was conducted to identify patients with schizophrenia across Australia who have metabolic problems, and look at the various interventions that might be effective for them. In this interview we discuss the key findings.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. David Castle, St Vincent’s Hospital Melbourne and the University of MelbourneProf. David Castle, St Vincent’s Hospital Melbourne and the University of Melbourne
Psy.4.2The importance of improving interest, pleasure and emotional range when treating major depressive disorder (15 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry. When treating depression what do patients want, ‘to ameliorate depressive symptoms’ or ‘to return to normal functioning’? In this interview we discuss individualised management that takes patient’s symptoms priorities and treatment expectations into account.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. David Castle, St Vincent’s Hospital Melbourne and the University of MelbourneProf. David Castle, St Vincent’s Hospital Melbourne and the University of Melbourne
Epi.2The use of antiepileptic drugs in pregnancy (38 mins)
00:00
Preview
10 seconds
Show more information

Epilepsy: In Australia, up to 2,000 women on anti-epileptic drugs become pregnant each year but there is concern, particularly in the neurological community, about the possible risks for these drugs and their teratogenicity. Neurologists have to balance the risks of both seizures and the risks of the medications and striking a balance is difficult – listen to learn more.
38-minute listen

Hosted by

Professor Mark Cook

Interviewees

  • Professor Frank Vajda, Epileptologist & Director of the Australian Pregnancy Registry for Women on Anti-epileptic Medications, MelbourneProfessor Frank Vajda, Epileptologist & Director of the Australian Pregnancy Registry for Women on Anti-epileptic Medications, Melbourne
Epi.1We now have more options in the medical treatment of epilepsy: A case study review (30 mins)
00:00
Preview
10 seconds
Show more information

Epilepsy: Epilepsy is one of the most common neurological illnesses, affecting three to four per cent of people in the developing world, and while we have a wealth of treatment options, many of these are now very old. In this interview we focus on the treatment options available to us as physicians and look at what this means to the patient and what factors we ought to consider.
30-minute listen

Hosted by

Professor Mark Cook

Interviewees

  • Associate Professor Piero Perucca, Neurologist, Royal Melbourne Hospital, Alfred Hospital, MelbourneAssociate Professor Piero Perucca, Neurologist, Royal Melbourne Hospital, Alfred Hospital, Melbourne
Endo.1Atypical case studies in menopausal hormone therapy (32 mins)
00:00
Preview
10 seconds
Show more information

Endocrinology. In this interview we discuss cases which are less than typical, the sort of patients that we are often referred by general practitioners. We apply the evidence to; Migraine, VTE, BRCA 1 and 2, and premature ovarian insufficiency, all situations that we’re more likely to see in secondary care. 30-minute listen

Hosted by

Professor Rod Baber

Interviewees

  • Dr Sonia Davison, Endocrinologist, Jean Hailes, Melbourne Dr Sonia Davison, Endocrinologist, Jean Hailes, Melbourne
Endo.2The evolving landscape of MHT (20 mins)
00:00
Preview
10 seconds
Show more information

Endocrinology: There’s been a spotlight on hormone therapy and breast cancer recently. Research is showing that women do not understand the long-term health consequences of menopause. So, what do we need to consider and how should we explain the multidimensional effects of menopause and of hormone therapy to our patients? 20-minute listen

Hosted by

Professor Rod Baber

Interviewees

  • Professor Susan Davis, Professor of Women’s Health, Melbourne & President, the International Menopause SocietyProfessor Susan Davis, Professor of Women’s Health, Melbourne & President, the International Menopause Society
Oph.1Pragmatic considerations to reduce the burden of bilateral anti-VEGF injections (19 mins)
00:00
Preview
10 seconds
Show more information

Ophthalmology. Many patients either present with bilateral disease or progress when having the macula affected in one eye, to both eyes within a few years. The key clinical question is; how clinical practice should be adapted when moving from unilateral to bilateral anti-VEGF therapy. In this interview we discuss pragmatic considerations to reduce the burden of bilateral anti-VEGF injections while mitigating any additional risks.

Hosted by

Professor Paul Mitchell

Interviewees

  • Associate Professor Alex Hunyor, Retinal Specialist, the University of SydneyAssociate Professor Alex Hunyor, Retinal Specialist, the University of Sydney
Oph.2Optimal anti-VEGF therapy regimen – A Vision Academy recommendation (28 mins)
00:00
Preview
10 seconds
Show more information

Ophthalmology. Since the introduction of anti-VEGF therapies, real world outcomes have generally not been as good as those observed in the trials. The question is whether this is due to the use of reactive approaches to therapy or whether proactive approaches to therapy might actually be better, and is there any evidence for ophthalmologists moving to proactive therapy. We discuss some of these questions in this interview.

Hosted by

Professor Paul Mitchell

Interviewees

  • Associate Professor Andrew Chang, Principal Retinal Specialist, Sydney Retina Clinic and Day SurgeryAssociate Professor Andrew Chang, Principal Retinal Specialist, Sydney Retina Clinic and Day Surgery
Res.2Treatment of idiopathic pulmonary fibrosis (25 mins)
00:00
Preview
10 seconds
Show more information

Respiratory. A lot has changed in the world of pulmonary fibrosis in the last few years, in terms of what treatments are available and what this means for our patients. We now have options to slow disease progression down and to prolong life, listen to learn more.

Hosted by

Professor John Upham

Interviewees

  • A/Prof Tamera Corte, Interstitial Lung Disease Specialist, Royal Prince Alfred Hospital, SydneyA/Prof Tamera Corte, Interstitial Lung Disease Specialist, Royal Prince Alfred Hospital, Sydney

Search Interviews

By area of interest:

Exclusively for Australian healthcare professionals
×

Tap the share icon ios share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!